{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:39:39Z","timestamp":1760985579628},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>Iron deficiency anemia (IDA) is the most common nutritional deficiency in children. Most children with IDA are treated with oral iron preparations. However, intravenous (IV) iron is an alternative for children with severe IDA who have difficulty in adhering to or absorbing oral iron. We sought to describe the safety and effectiveness of IV iron sucrose for treatment of IDA in children. Pharmacy records of children who received IV iron sucrose at a children\u2019s hospital between 2004 and 2014 were reviewed. Laboratory markers of anemia and iron studies were obtained and preinfusion and postinfusion values were compared. Records were also reviewed for adverse reactions. A total of 142 patients received IV iron sucrose over 10 years. The mean age was 11 years, 9 months. One patient of 142 developed cough and wheezing during the infusion. No other adverse events were found. IV iron sucrose resulted in a statistically significant and clinically meaningful increase in hemoglobin, mean corpuscular volume, serum iron, ferritin, and % iron saturation, with a corresponding decrease in total iron binding capacity. The use of IV iron sucrose in pediatric patients with IDA is safe and leads to a moderate increase in hemoglobin and substantial improvement in iron studies.<\/jats:p>","DOI":"10.1097\/mph.0000000000000879","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T16:20:37Z","timestamp":1496247637000},"page":"e259-e262","source":"Crossref","is-referenced-by-count":24,"title":["Intravenous Iron Sucrose for Children With Iron Deficiency Anemia"],"prefix":"10.1097","volume":"39","author":[{"given":"Kristiyana","family":"Kaneva","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Children\u2019s Hospital Los Angeles, Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Chow","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy G.","family":"Rosenfield","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, The Floating Hospital for Children at Tufts Medical Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, The Floating Hospital for Children at Tufts Medical Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archpedi.162.4.374","article-title":"Secular trends in the prevalence of iron deficiency among US toddlers, 1976\u20132002","volume":"162","author":"Brotanek","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1542\/peds.2010-2576","article-title":"Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0\u20133 years of age)","volume":"126","author":"Baker","year":"2010","journal-title":"Pediatrics"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1753-4887.2011.00431.x","article-title":"Consumption of cow\u2019s milk as a cause of iron deficiency in infants and toddlers","volume":"691","author":"Ziegler","year":"2011","journal-title":"Nutr Rev"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1542\/peds.2009-2097","article-title":"Iron deficiency anemia and cognitive function in infancy","volume":"126","author":"Carter","year":"2010","journal-title":"Pediatrics"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/pr.2012.22","article-title":"Long-term neuroendocrine effects of iron-deficiency anemia in infancy","volume":"71","author":"Felt","year":"2012","journal-title":"Pediatr Res"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1542\/peds.105.4.e51","article-title":"Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy","volume":"105","author":"Lozoff","year":"2000","journal-title":"Pediatrics"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/156482651003100305","article-title":"Psychomotor development in children with iron deficiency and iron-deficiency anemia","volume":"31","author":"Pala","year":"2010","journal-title":"Food Nutr Bull"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/08860220701278208","article-title":"Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?","volume":"29","author":"Sav","year":"2007","journal-title":"Ren Fail"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pbc.24676","article-title":"Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron","volume":"60","author":"Plummer","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08880018.2013.829540","article-title":"Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia","volume":"31","author":"Akin","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pbc.22930","article-title":"Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy","volume":"56","author":"Crary","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20230918","first-page":"335","article-title":"Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia","volume":"10","author":"Pinks","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2146\/ajhp070222","article-title":"Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia","volume":"65","author":"Wall","year":"2008","journal-title":"Am J Health Syst Pharmacol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pbc.25752","article-title":"Advances in pediatric intravenous iron therapy","volume":"63","author":"Mantadakis","year":"2016","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201707000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:11:27Z","timestamp":1695010287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201707000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000879","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}